Medical device and MedTech insights, news, tips and more

WISE Receives FDA Clearance for its WISE Cortical Strip Bringing Neuromonitoring to the Next Level

December 5, 2022

Cortical grids photography for Wise

WISE Srl, a medical device company developing next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing (BMI), announced the FDA clearance of its WISE Cortical Strip (WCS®), a single use medical device intended to be used on the brain surface for Intra Operative Neurophysiological Monitoring (IONM).

The WISE Cortical Strip is the first product receiving FDA clearance within the Company’s WISEneuro® Monitoring product family. The FDA clearance follows the CE mark already received by the product in May 2021.

The WISE Cortical Strip performances have been successfully validated in a multicentric pre-market clinical study in Europe, the WIN study (NCT03731455), that demonstrated safety, performance and usability of the product. The study showed that the WISE Cortical Strip has better performance in terms of electrical impedance in physiological conditions than conventional cortical electrodes available on the market, as well as better adhesion, conformability and stability on the brain surface. The WIN study data was recently published on the journal Clinical Neurophysiology (

The WISE Cortical Strip is intended for intraoperative use with recording, monitoring and stimulation equipment for the recording, monitoring, and stimulation of electrical signals on the brain surface. Unlike traditional cortical electrodes, which are made of stiff metal discs enclosed in a thick silicone foil, the WISE Cortical Strip is composed of stretchable platinum contacts embedded in a soft and thin film of silicone. As a result, the WISE Cortical Strip is highly ergonomic and conformable to the brain surface.

After the successful FDA clearance of the device, the Company is now aiming to expand its WISEneuro® Monitoring product family, that will comprise strips and grids with varying thickness, and with embedded contacts of a wide range of shapes, density, numbers or sizes, and to complete the development of its Heron® lead for Spinal Cord Stimulation (SCS), the first expandable percutaneous paddle lead that pain therapists and neurosurgeons will be able to implant percutaneously.

Luca Ravagnan, CEO of WISE said: “The FDA clearance is a crucial milestone for our commercial development, allowing to expand the distribution of the WISE Cortical Strip from Europe to the US and fueling the development of the WISEneuro® Monitoring product family. European clinicians are already demonstrating strong appreciation for the benefits of our product, we are looking forward to starting commercialization also in the US.”

For more information, please visit:

About WISE
WISE Srl has developed a genuinely new generation of electrodes for neuromonitoring, neuromodulation and brain machine interfacing by means of its proprietary Supersonic Technology.

Neuromonitoring and neuromodulation require electrodes and leads to be surgically implanted on neural tissues (as for instance the brain and the spinal cord) to apply electrical stimuli or to record the electrical activity. The electrodes produced using WISE’s Supersonic Technology consist of stretchable electronic circuits integrated in very thin elastomeric foils. As a result, WISE’s electrodes are highly ergonomic, conformable, soft and thin, thus allowing great adhesion, minimal invasiveness and excellent adaptability on neural tissues.

WISE is also active in the field of neuromodulation, developing its WISEneuro® Modulation product family. The first product of this line will be the Heron® lead, the first expandable percutaneous paddle lead for Spinal Cord Stimulation that pain therapists and neurosurgeons will be able to implant percutaneously.

See Full Press Release at the Source: WISE Receives FDA Clearance for its WISE Cortical Strip Bringing Neuromonitoring to the Next Level

Press Release by: WISE Srl

Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.